Functional constipation in children: a mini-review for primary care management

INTRODUCTION

Functional constipation (FC) is one of the most prevalent chronic gastrointestinal disorders in childhood and accounts for up to 3-5% of all pediatric visits and as many as 25% of referrals to pediatric gastroenterology clinics.^1-3 Despite its frequency, FC is often underestimated by families and clinicians because symptoms may fluctuate and children may appear otherwise well. Untreated or inadequately managed FC can lead to prolonged stool retention, abdominal discomfort, fecal incontinence, school avoidance, and a significant reduction in quality of life for both the child and the family.^4,5 These consequences highlight the importance of timely recognition and effective early intervention, particularly in primary-care settings where most cases initially present.

A clear understanding of FC requires appreciating both its behavioral and physiological components. Many children experience a painful bowel movement often triggered by transient dietary changes, mild dehydration, illness, or environmental stressors leading to voluntary stool withholding. Behavioral avoidance patterns such as stiffening, hiding, or clenching the gluteal muscles are frequently misinterpreted as straining rather than withholding.^6-8 Over time, this cycle results in progressive rectal distension, reduced rectal sensation, and larger, harder stools that reinforce the pattern. These dynamics help explain why symptom chronicity is common and why early, structured intervention is essential to prevent long-term sequelae.

Primary-care clinicians are uniquely positioned to diagnose and manage FC effectively. Rome IV criteria offer a symptom-based diagnostic framework that avoids unnecessary testing in children without red flags.^6,7 Overuse of abdominal radiography, routine blood work, or invasive testing continues to be a challenge, despite guideline recommendations to reserve these evaluations for children with concerning features such as failure to thrive, severe abdominal distension, delayed passage of meconium, or neurologic findings.^9-11 A thorough history, review of stool patterns, withholding behaviors, and psychosocial context remain far more valuable than routine imaging in differentiating FC from organic causes.

The burden of FC extends beyond gastrointestinal symptoms. Children may experience embarrassment, social withdrawal, bullying at school, or academic difficulties related to frequent absences. Family stress also increases, especially when symptoms persist despite parental efforts. These psychosocial impacts are well documented, with quality-of-life studies showing significant impairment in both children and caregivers.^4,5 Acknowledging these factors is essential for empathetic counseling and for promoting adherence to long-term management plans.

The purpose of this mini-review is to provide primary-care clinicians with a concise, practical synthesis of the most current evidence and guidelines. Emphasis is placed on diagnostic clarity, stepwise treatment using disimpaction and maintenance therapy, integration of behavioral strategies, prevention of relapse, and indications for specialist referral. By distilling the core elements of recent guidelines and contemporary research, this review aims to support efficient, family-centered management and improve long-term outcomes for children with functional constipation.^7,9,12

DEFINITION AND PATHOPHYSIOLOGY

FC in children is defined according to the Rome IV criteria, which emphasize a symptom-based approach rather than routine laboratory or radiologic evaluation. Rome IV provides age-specific diagnostic thresholds and requires the presence of characteristic symptoms for a minimum duration—at least one month in children aged four years and older, and two months in younger children. These symptoms include infrequent bowel movements (≤2 per week), episodes of fecal incontinence in toilet-trained children, painful or hard stools, excessive stool withholding, the passage of large-caliber stools, and the presence of a palpable fecal mass. The Rome framework empowers primary-care clinicians to make a confident diagnosis using careful history and examination rather than excessive testing.^6,7

In toddlers and preschool-aged children, developmental factors contribute significantly to symptom presentation. Toilet training, increasing autonomy, and heightened sensitivity to environmental stressors influence bowel habits. Painful defecation following dietary changes, mild illness, or dehydration frequently triggers negative associations with toileting. This may lead to stool withholding behavior, a hallmark of FC. Without red flags such as delayed meconium passage, poor growth, severe abdominal distension, neurologic deficits, or persistent vomiting, guideline recommendations strongly discourage routine imaging or laboratory studies. A detailed history of stool patterns and withholding postures is usually more informative than diagnostic tests.^9-11

The pathophysiology of FC centers on the self-perpetuating “pain–withholding cycle,” which begins with a painful bowel movement. Anticipating discomfort, the child voluntarily postpones defecation, often displaying subtle or dramatic withholding behaviors such as crossing the legs, stiffening, tiptoeing, or hiding. Families may misinterpret these signs as attempts to push rather than suppress stool. As stool remains in the rectum, water continues to be absorbed, producing larger, drier, and harder stools. These stools cause more pain when passed, reinforcing withholding behavior.^6-8

Continued retention leads to progressive rectal distension. The rectal wall adapts by becoming increasingly compliant, reducing sensory perception of fullness known as rectal hyposensitivity. As the rectum enlarges, the natural urge to defecate diminishes. In advanced cases, softer stool may bypass the impacted mass, resulting in overflow incontinence. This phenomenon is often misinterpreted by parents as diarrhea rather than a sign of severe fecal retention.^6,13 Chronic distension may impair rectal muscle contractility, further delay recovery and necessitating prolonged maintenance therapy.

Dietary and environmental factors also play roles. Low fiber intake, inadequate hydration, high dairy consumption, and sedentary habits can contribute to firmer stool consistency and slower colonic transit. Psychosocial factors—such as school bathroom avoidance, stress, anxiety, or changes in routine may exacerbate withholding and disrupt normal toileting patterns. Recent literature highlights the possible contribution of gut microbiota dysbiosis to stool form and colonic motility, though clinical applicability remains preliminary and does not currently alter guideline-based management.^4,12

FC is therefore best understood as a multidimensional disorder involving behavioral, physiological, and environmental components. Painful defecation leads to withholding, which produces progressive fecal retention, rectal dilation, and sensory impairment completing a cycle that sustains constipation over weeks to months. Recognizing this cycle helps clinicians explain the condition to families, reinforce adherence, and justify the need for a combination of disimpaction, maintenance therapy, behavioral strategies, and nutritional support. Breakthrough typically requires both medical and behavioral interventions applied consistently over time.

RED FLAGS AND WHEN TO REFER

Although FC accounts for the majority of constipation cases in childhood, clinicians must remain alert to red-flag features that suggest an underlying organic disorder. Early recognition prevents delayed diagnosis of conditions such as Hirschsprung disease, celiac disease, spinal dysraphism, metabolic disorders, endocrine abnormalities, or structural gastrointestinal lesions.^7,9 A detailed history and targeted physical examination remain central to differentiating FC from these potentially serious conditions.

Historical red flags are especially important. Delayed passage of meconium beyond 48 hours in a term newborn strongly raises suspicion for Hirschsprung disease. Constipation beginning before one month of age, poor response to standard therapy, or persistent vomiting particularly if bilious should prompt evaluation for congenital or obstructive causes. Other concerning features include failure to thrive, unintentional weight loss, poor feeding, fever, rectal bleeding without fissures, and marked abdominal distension.^9,10 Children with developmental regression, abnormal neurologic signs, or chronic diarrhea alternating with constipation may also require prompt referral. A thorough family history is helpful; having relatives with Hirschsprung disease, spinal anomalies, autoimmune disorders, or endocrine disease increases the likelihood of an organic etiology. Common organic causes that warrant exclusion are listed in Table 1.

Physical examination can reveal additional signs warranting further investigation. The presence of severe abdominal distension, a firm fecal mass accompanied by systemic symptoms, a non-patent or anteriorly displaced anus, or absent anal wink suggests structural or neurologic involvement.

Lumbosacral findings, such as a deep sacral dimple, hair tuft, deviated gluteal cleft, or sacral agenesis, are associated with occult spinal dysraphism and require imaging. Endocrine abnormalities including bradycardia, hypotonia, dry skin, or goiter raise concern for hypothyroidism and merit laboratory evaluation.^10,11 Key alarm signs on history and physical examination are summarized in Table 2.

Clinicians should also consider red flags when symptoms persist despite optimized management. If a child fails to improve after appropriate disimpaction, daily maintenance therapy, and adherence to behavioral strategies, alternative diagnoses should be explored. These may include cow’s milk protein allergy, celiac disease, or motility disorders. Laboratory testing is generally unnecessary unless such features are present. When indicated, evaluation may include thyroid studies, celiac serology, calcium levels, or abdominal imaging but only when justified by clinical suspicion.^9-11

Referral to pediatric gastroenterology is recommended when any red flags are present or when symptoms are refractory to well-structured primary-care management. Early referrals prevent unnecessary delays and ensure timely motility testing, rectal biopsy, advanced imaging, or multidisciplinary evaluation when needed.

MANAGEMENT

Effective management of FC requires a structured, stepwise, and family-centered approach that addresses both the physiological consequences of stool retention and the behavioral patterns that perpetuate withholding. The most common reasons for inadequate response are incomplete disimpaction, premature discontinuation of maintenance therapy, and inconsistent adherence to behavioral routines.¹ For primary-care clinicians, a clear framework can markedly improve outcomes, reduce unnecessary referrals, and prevent chronic recurrences.

The management of FC can be divided into four interconnected components: education and behavioral modification, disimpaction, maintenance therapy, and follow-up with relapse prevention.

Non-pharmacologic strategies

Effective management of FC requires integrating behavioral, dietary, and pharmacologic strategies. Families often begin treatment with laxatives alone, but guidelines emphasize that long-term success depends equally on education, toilet habits, and consistent daily routines.^6,7 Primary-care clinicians play a crucial role in setting expectations, explaining the pathophysiology, and reinforcing the importance of prolonged maintenance therapy.

Education and counseling

The cornerstone of non-pharmacologic therapy is helping families understand the pain–withholding cycle. A single painful stool can trigger voluntary withholding, which leads to progressive fecal retention, rectal dilation, and reduced sensation—ultimately sustaining constipation. Explaining this mechanism improves adherence and reduces frustration when symptoms do not resolve immediately.^6,7 Parents should be reassured that episodes of overflow incontinence are not behavioral but reflect severe fecal loading.

Toilet habits and behavioral interventions

Structured toilet routines form a central component of treatment. Children should sit on the toilet for 5–10 minutes after meals particularly breakfast and dinner to benefit from the gastrocolic reflex. Proper foot support is essential to stabilize the pelvis and optimize recto-anal angle. Positive reinforcement (sticker charts, rewards) is more effective than punishment or criticism. Coordination with school staff may be necessary for children who avoid school bathrooms.^9-11 Avoiding prolonged holding at school is particularly important.

Dietary measures

Dietary recommendations focus on normalizing stool consistency. Increasing fiber intake to approximately “age (years) + 5 grams per day” and ensuring adequate hydration are practical, widely used strategies. Excessive dairy intake, low fluid consumption, high intake of processed snacks, and limited fruit/vegetable consumption are common contributors. Fruits such as prunes, pears, and kiwis may improve stool frequency. While recent research has explored the role of gut microbiota in FC, probiotics have shown inconsistent results and are not routinely recommended.^1,9,12

Physical activity

Regular physical activity supports gastrointestinal motility and may reduce stool retention. Although evidence remains modest, encouraging daily outdoor play and reducing excessive sedentary time is a reasonable adjunct.^1,4

Non-pharmacologic measures alone are rarely sufficient to resolve established FC, particularly when rectal distension is present. They should therefore be initiated alongside pharmacologic therapy for best outcomes.

Pharmacologic management

Pharmacologic therapy is the foundation of effective treatment for FC. Because most children present with significant stool retention and rectal distension, medication is required to both clear the obstructing stool and restore normal rectal tone. Guidelines emphasize a two-step pharmacologic approach: disimpaction, followed by long-term maintenance therapy.^7,14 Attempting maintenance therapy without proper disimpaction is one of the most common reasons for treatment failure.

Disimpaction

Polyethylene glycol (PEG) is the recommended first-line agent for disimpaction due to its superior efficacy, safety profile, and palatability. Multiple systematic reviews and trials confirm that PEG effectively achieves fecal clearance with fewer adverse effects compared to enemas or other oral agents.^14,15

Dose was PEG 1–1.5 g/kg/day for 3–6 days, with some children requiring up to 7 days. The goal is to achieve large-volume, watery stools indicating rectal evacuation. Families should be informed that high-dose PEG will cause frequent loose stools and possibly abdominal cramping this is expected and temporary.

If PEG alone is insufficient, a short course of a stimulant laxative (senna or bisacodyl) may be added. Stimulants act by enhancing colonic motility and are particularly useful in children with severe rectal dilation or weak urge to defecate.^14,15

Enemas (saline, mineral oil, or sodium phosphate) may be used only when PEG is unavailable or not tolerated, as they are more invasive and less child-friendly. Sodium phosphate enemas should be avoided in younger children due to the risk of electrolyte disturbances.⁹

Maintenance therapy

Maintenance therapy prevents reaccumulation of stool, allows the rectum to gradually return to normal size, and helps restore rectal sensation. Treatment must be continued for months not weeks.

PEG remains the first-line maintenance agent, with robust evidence demonstrating superior stool frequency, improved stool consistency, and fewer side effects compared with lactulose, milk of magnesia, or mineral oil.^2,14

Dose- PEG 0.4–0.8 g/kg/day, titrated to achieve 1 soft stool per day (Bristol 4). A minimum of 2–3 months, and at least 1 month after all symptoms resolve should be used. Many children require 4–6 months or longer depending on the severity of rectal dilation.

Alternative maintenance agents

Lactulose, effective but less preferred due to gas and bloating, Magnesium hydroxide is useful in older children but should be avoided in renal impairment. Mineral oils were effective lubricant but risk of aspiration and should be avoided in young children.

Short “rescue doses” of stimulant laxatives (senna or bisacodyl) may be used intermittently if stool softeners alone do not maintain adequate bowel movements.^9,14,15 These should be clearly explained to families to avoid overuse. Recommended dosing regimens and commonly used agents are summarized in Table 3.

Medication safety and expectations

Parents should be reassured that long-term PEG use is safe, has no habit-forming properties, and does not lead to dependence or structural bowel damage.^2,14 The most common reasons for relapse include under-dosing, inconsistent use, or premature discontinuation. Clinicians should emphasize that symptoms often return if medication is stopped before the rectum has fully recovered.

Follow-up

Regular follow-up is essential to ensure successful management of FC. Even when families are highly motivated, treatment failure commonly occurs due to inadequate disimpaction, subtherapeutic maintenance dosing, or premature tapering of medication. For this reason, guidelines emphasize structured reassessment in the early phases of therapy.^10-12

Children should be reviewed every 2–4 weeks during the initial months of treatment. At each visit, the clinician should evaluate stool frequency, consistency, withholding behaviors, abdominal symptoms, and adherence to medication. Stool diaries or digital tracking tools can improve accuracy and help families visualize progress.^10-12 Persistent large-caliber stools, painful defecation, or recurrent incontinence indicate incomplete disimpaction or insufficient maintenance dosing and warrant dose adjustment.

When symptoms improve but have not fully resolved, clinicians should resist the temptation to reduce medication prematurely. Rectal dilation can take several weeks to months to normalize, and reduction of therapy before this occurs often results in relapse. Families benefit from clear expectations that treatment is a long-term process and that medication adjustments are part of a normal management pathway rather than a sign of worsening disease.

Follow-up visits are also an opportunity to reinforce toilet routines, hydration, physical activity, and behavioral strategies. Coordination with schools may be required for children who avoid toileting during class hours or lack adequate bathroom access. If progress remains limited despite optimized therapy, or if new concerning features appear, clinicians should revisit the possibility of red flags and consider targeted evaluation or referral.

Effective follow-up transforms a static treatment plan into a dynamic, individualized care pathway, enabling families to sustain improvements and avoid the chronic pattern often seen in untreated FC.^10-12

Preventing relapse

Relapse is common in FC, particularly when families discontinue treatment too early or when daily routines become inconsistent. Preventing relapse requires reinforcing the chronic nature of FC and clearly explaining that recovery involves gradual reversal of rectal dilation and restoration of normal sensation processes that take time. Early normalization of stool frequency does not necessarily indicate complete resolution of underlying pathophysiology, and symptoms often return if maintenance therapy is tapered prematurely.^9,10

Families should be advised that even after full clinical improvement, stool-softening therapy should continue for at least one month and often longer if rectal dilation was significant. Many children benefit from a slow, stepwise dose reduction rather than abrupt discontinuation. A “rescue plan,” including temporary dose increases or brief use of stimulant laxatives, can help manage early warning signs such as hard stools, painful defecation, or renewed withholding. Consistency in toilet routines, hydration, diet, and activity remains as important during the recovery phase as during initial treatment. Relapses frequently occur during periods of disruption illness, travel, school transitions, or holidays when routines are harder to maintain. Families should be encouraged to anticipate these situations and adjust accordingly. For example, increasing PEG doses during travel or after missed stools can prevent reaccumulation. Providing caregivers with clear, written instructions improves confidence and reduces unnecessary medical visits.^11,12

Regular follow-up also plays a preventive role. Scheduled reassessments every few weeks allow clinicians to identify early signs of relapse and intervene before symptoms escalate. Emphasizing a long-term, proactive approach reassures families and helps break the cycle of intermittent improvement followed by recurrence that characterizes poorly managed FC.^10-12

SUMMARY TABLE AND ALGORITHM EXPLANATION

Management of FC in children is most effective when clinicians follow a structured, stepwise approach that integrates education, disimpaction, maintenance therapy, and behavioral strategies. To support efficient decision-making in busy primary-care settings, a consolidated summary table and a simplified algorithm are provided below. These tools translate guideline-based recommendations into practical, actionable steps for clinicians and families.

A concise overview of practical management steps is provided in Table 4. This table outlines the essential domains of FC management, including diagnostic criteria, identification of red flags, non-pharmacologic strategies, pharmacologic therapy, follow-up intervals, and relapse-prevention measures. This format allows clinicians to quickly review recommended PEG dosing ranges, indicators of incomplete disimpaction, behavioral reinforcements, and indications for referral.^7,9 By presenting these elements side by side, the table enhances consistency across providers and minimizes common pitfalls such as under-dosing, premature discontinuation of treatment, or inadequate toilet routines.^10,11

As illustrated in Figure 1, the accompanying algorithm provides a visual step-by-step guide that mirrors the clinical workflow used in primary care. It begins with initial evaluation and the exclusion of red-flag symptoms, followed by immediate disimpaction when FC is diagnosed, then transitions into maintenance therapy and behavioral reinforcement. A separate decision path highlights when to escalate care or refer to pediatric gastroenterology. This clear sequencing helps clinicians avoid skipping essential steps, particularly the common error of starting maintenance therapy without proper disimpaction.^9-11

Together, the table and algorithm emphasize that successful treatment requires both medical therapy and daily routines to be maintained over time. Families benefit from seeing these steps visually, as they clarify expectations and promote adherence. These tools serve as quick-reference resources that complement the narrative sections of this review and support high-quality, guideline-based care in the primary-care setting.

CONCLUSION

FC is one of the most common chronic gastrointestinal complaints in childhood and carries a substantial burden for children, families, and healthcare systems. Although typically benign, chronic stool retention can result in significant discomfort, fecal incontinence, and psychosocial distress, underscoring the importance of early and structured intervention. By applying a systematic approach rooted in guideline-based principles, primary-care clinicians can successfully diagnose and manage most cases without extensive testing or specialist referral.

This review emphasizes the central role of the pain–withholding cycle and the long-term consequences of rectal dilation. Effective treatment requires complete disimpaction, followed by sustained maintenance therapy and behavioural changes that normalize stool patterns and support rectal recovery. Parents benefit greatly from clear expectations and reassurance that long-term use of polyethylene glycol is safe and supported by evidence. Behavioural strategies including structured toilet routines, hydration, dietary optimization, and consistent reinforcement remain essential components of management and improve adherence over time.

Relapses are common when therapy is tapered prematurely or when routines become inconsistent, particularly during times of stress, illness, or travel. Ongoing follow-up allows clinicians to identify early warning signs and intervene before symptoms recur. With proactive support, most children achieve long-term resolution of symptoms and improved quality of life.

Ultimately, FC requires a family-centered, multidisciplinary approach that combines medical, behavioural, and educational strategies. By adopting a structured and empathetic framework, primary-care clinicians can significantly improve outcomes and reduce the long-term burden of functional constipation in children.

Funding: No funding sources

Conflict of interest: None declared

Ethical approval: Not required

REFERENCES

1. 1. Tran DL, Sintusek P. Functional constipation in children: what physicians should know. World J Gastroenterol. 2023;29(8):1261-88.
2. 2. Bashir SK, Khan MB, Yu J. Pediatric functional constipation: a new challenge. Adv Gut Microbiome Res. 2024;2024:5569563.
3. 3. Robin SG, Keller C, Zwiener R, Hyman PE, Nurko S, Saps M, et al. Prevalence of Pediatric Functional Gastrointestinal Disorders Utilizing the Rome IV Criteria. J Pediatr. 2018;195:134-9.
4. 4. Pan Y, Jiao FY. Addressing functional constipation in children: a call for comprehensive and collaborative management. World J Gastroenterol. 2025;31(7):98889.
5. 5. Vriesman MH, Rajindrajith S, Koppen IJN, van Etten-Jamaludin FS, van Dijk M, Devanarayana NM, et al. Quality of Life in Children with Functional Constipation: A Systematic Review and Meta-Analysis. J Pediatr. 2019;214:141-50.
6. 6. Hyams JS, Di Lorenzo C, Saps M, Shulman RJ, Staiano A, van Tilburg M. Functional Disorders: Children and Adolescents. Gastroenterology. 2016;S0016-5085(16)00181-5.
7. 7. Tabbers MM, DiLorenzo C, Berger MY, Faure C, Langendam MW, Nurko S, et al. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr. 2014;58(2):258-74.
8. 8. Ho JMD, How CH. Chronic constipation in infants and children. Singapore Med J. 2020;61(2):63-8.
9. 9. Mulhem E, Khondoker F, Kandiah S. Constipation in Children and Adolescents: Evaluation and Treatment. Am Fam Physician. 2022;105(5):469-78.
10. 10. NHS England. National primary care clinical pathway for constipation in children. 2023. Available at: https://www.england.nhs.uk/. Accessed on 07 October 2025.
11. 11. Alberta Health Services. Pediatric Constipation Primary Care Pathway. Alberta Health Services. 2023. Available at: https://albertahealthservices.ca/assets/about/scn/ahs-scn-dh-pathway-pediatric-constipation.pdf. Accessed on 07 October 2025.
12. 12. Allen P, Setya A, Lawrence VN. Pediatric Functional Constipation. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2025. Available at: https://www.ncbi.nlm.nih.gov/books/NBK537037/. Accessed on 07 October 2025.
13. 13. van der Zande JMJ, Koppen IJN, Di Lorenzo C, Lu PL, Benninga MA. Pharmacological treatment for children with constipation: present and future. Expert Opin Pharmacother. 2025;26(5):519-24.
14. 14. de Geus A, Koppen IJN, Flint RB, Benninga MA, Tabbers MM. An update of pharmacological management in children with functional constipation. Paediatr Drugs. 2023;25(3):343-58.
15. 15. Jonker CAL, van Os TM, Gorter RR, Levitt MA, Benninga MA. Current Treatment Options for Children with Functional Constipation-What Is in the Pipeline? Children (Basel). 2025;12(7):857.